Mitotic Inhibitors: Taxanes and Vinca Alkaloids

## Overview

Mitotic inhibitors target the mitotic spindle, a structure composed of microtubule polymers that segregate chromosomes during cell division. Disruption of microtubule dynamics triggers the spindle assembly checkpoint, causing mitotic arrest and apoptotic cell death. These drugs are M-phase specific and are among the most effective anticancer agents.

## Microtubule Biology

Microtubules are dynamic polymers of alpha/beta-tubulin dimers that undergo rapid assembly (polymerization) and disassembly (depolymerization) — a process called dynamic instability. This treadmilling behavior is essential for spindle formation and chromosome segregation. Drugs that either stabilize or destabilize microtubules abolish dynamic instability, preventing proper spindle function.

## Taxanes (Microtubule Stabilizers)

Taxanes bind to the beta-tubulin subunit on polymerized microtubules, stabilizing them and preventing depolymerization. This freezes the spindle, activates the spindle assembly checkpoint, and induces apoptosis.

**Paclitaxel (Taxol)** is derived from the Pacific yew tree. It is formulated in Cremophor EL (causing hypersensitivity reactions; premedicate with dexamethasone, diphenhydramine, and H2 antagonists) or as nab-paclitaxel (albumin-bound, avoids Cremophor). Used in breast, ovarian, NSCLC, and gastric cancers.

**Docetaxel** has greater binding affinity for tubulin than paclitaxel and is active in breast, prostate (CRPC), NSCLC, and gastric cancers. Causes fluid retention (manage with dexamethasone premedication).

**Cabazitaxel** is a semi-synthetic taxane that overcomes P-glycoprotein-mediated resistance to docetaxel; used in CRPC after docetaxel failure.

## Vinca Alkaloids (Microtubule Destabilizers)

Vinca alkaloids (from Catharanthus roseus) bind to beta-tubulin at the vinca domain, preventing polymerization and causing microtubule depolymerization. Spindle formation fails, and mitotic arrest triggers apoptosis.

**Vincristine** is used in lymphomas, leukemias (ALL induction), and pediatric solid tumors. Its dose-limiting toxicity is peripheral neuropathy (not myelosuppression), allowing it to be combined with myelosuppressive agents without additive marrow toxicity.

**Vinblastine** causes more myelosuppression and less neuropathy than vincristine. Used in Hodgkin lymphoma (ABVD) and testicular cancer (BEP).

**Vinorelbine** is used in NSCLC and breast cancer; available orally and IV.

## Key Takeaways

- Taxanes stabilize microtubules (prevent depolymerization); vinca alkaloids destabilize them (prevent polymerization)
- Both classes cause mitotic arrest via spindle assembly checkpoint activation
- Vincristine is dose-limited by neuropathy, not myelosuppression — important for combination design
- Nab-paclitaxel avoids Cremophor-related hypersensitivity; cabazitaxel overcomes taxane resistance